QST by compound
QST records split by compound, with the index-wide comparison for the same compound beside each one. 4 compounds, 20 records. Cells below n=3 print their raw values instead of a median.
| Compound | Class | Reports | QST median % | Index median % | Δ (pp) | Spec | Pass % |
|---|---|---|---|---|---|---|---|
| Tirzepatide | Incretin | 11 | 98.40 | 98.55 | -0.15 | 97.0 | 100 |
| NAD+ | Non-peptide | 7 n=7 | 98.06 | 99.28 | -1.22 | 97.0 | 100 |
| MOTS-c | Metabolic | 1 n=1 | n<3 | 99.13 | — | 98.0 | 100 |
| GHRP-6 | Growth-hormone | 1 n=1 | n<3 | 99.54 | — | 99.0 | 0 |
Which of these lines QST actually stocks
Coverage here reflects what has been submitted to the index, not what is on the catalogue. Qingdao Saber Technology Pharmaceutical lists considerably more than the 4 compounds above. Of those 4, 2 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.